UBS Group’s Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share NGC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-425
Closed -$34 11263
2022
Q4
$34 Buy
+425
New +$41 ﹤0.01% 10519
2022
Q1
Sell
-150
Closed 11308
2021
Q4
$0 Sell
150
-1,146
-88% -$1.09K ﹤0.01% 11047
2021
Q3
$1K Buy
+1,296
New +$1.45K ﹤0.01% 9351

UBS Group's NGC.WS Position: Q1 2023 in Review

UBS Group sold out of Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share (NGC.WS) in Q1 2023, closing a stake of 425 shares — an estimated $34 sold.

UBS Group first reported a position in NGC.WS in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 0 funds tracked by Wall St. Rank hold NGC.WS as of Q1 2023.

  • UBS Group reported no remaining Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 425 Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $34.
  • UBS Group first reported a position in Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 3 quarters.
  • UBS Group's Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position peaked at $1K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.